Investing Profile

Kristina Burow

VCInvestor
Managing Director at ARCH Venture Partners
Photo of Kristina Burow, Managing Director at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, Berkeley Network
246 CONNECTIONS
The University of Chicago Booth School of Business Network
47 CONNECTIONS
cb
ARCH Venture Partners Managing Director
$50K - $150.0M
$50K
29
$635.8M
CompanyStageDateRound SizeTotal Raised
Mirador Therapeutics
Series AMar 2024$400M
$400M
Remix Therapeutics
Series UnknownJan 2024$60M
Series BMay 2022$70M
Series ADec 2020$65M
$210M
Co-investors: Kevin Bitterman (Atlas Venture), Michael Rome (Foresite Capital), Leon Chen (The Column Group), Peter Svennilson (The Column Group)
Magnet Biomedicine
Series ASep 2023$50M
$50M
Orbital Therapeutics
Series AApr 2023$270M
SeedSep 2022
$270M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Carol Suh (ARCH Venture Partners)
Pretzel Therapeutics
Series ASep 2022$73M
$73M
Co-investors: Per Samuelsson (HealthCap), Robert Tansley (Cambridge Innovation Capital), Jay Parrish (ARCH Venture Partners), Reetika Bhardwaj (ARCH Venture Partners), Alaa Halawa
Dewpoint Therapeutics
Series CFeb 2022$150M
Series BSep 2020$77M
$290M
Co-investors: Amir Nashat (Polaris Partners), Caleb Appleton (Bison Ventures), Vikas Parekh (SoftBank Vision Fund)
Neumora Therapeutics
Series AOct 2021$400M
$510M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Robert Nelsen (ARCH Venture Partners), Alaa Halawa
Vividion Therapeutics
Series CFeb 2021$140M
Series BApr 2019$82M
Series AFeb 2017$50M
$270M
Co-investors: Tom Woiwode (Versant Ventures), Jakob Loven (Nextech Invest)
Managing Director ARCH Venture PartnersPresent
University of California, Berkeley
The University of Chicago Booth School of Business MBA